Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-02-27
2008-12-23
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S119000
Reexamination Certificate
active
07468376
ABSTRACT:
New compounds of formula (I) and the salts, solvates and prodrugs thereof, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as p38 kinase inhibitors.
REFERENCES:
patent: 4264603 (1981-04-01), Lesher et al.
patent: 4375467 (1983-03-01), Lesher et al.
patent: 6693102 (2004-02-01), Stasch et al.
patent: 7135568 (2006-11-01), Gerlach et al.
patent: 2002/0013328 (2002-01-01), Sherk et al.
patent: 2005/0070542 (2005-03-01), Hodgetts et al.
patent: 1104145 (1968-02-01), None
patent: 0 063 754 (1982-11-01), None
patent: 9501980 (1995-01-01), None
patent: WO 99/30710 (1999-06-01), None
patent: 0026216 (2000-05-01), None
patent: 0127113 (2001-04-01), None
patent: 0130778 (2001-05-01), None
patent: WO 01/44244 (2001-06-01), None
patent: WO 01/53268 (2001-07-01), None
patent: 0194353 (2001-12-01), None
patent: 0216359 (2002-02-01), None
patent: WO 02/24694 (2002-03-01), None
patent: WO 02/062795 (2002-08-01), None
patent: WO 03/033502 (2003-04-01), None
patent: 03/068773 (2003-08-01), None
patent: WO 03/068773 (2003-08-01), None
patent: WO 2004/014368 (2004-02-01), None
patent: 2004056827 (2004-07-01), None
patent: 2004099203 (2004-11-01), None
patent: WO 2004/096130 (2004-11-01), None
Chen et al., Diabetologia, 2005, vol. 48, pp. 486-495.
Witherington, Jason, et al., “6-Aryl-pyrazolo[3,4-b]pyridines: Potent Inhibitors of Glycogen Synthase Kinase-3 (GSK-3),”Bioorganic&Medicinal Chemistry Letters, 13 (2003) 3055-3057.
Witherington, Jason, et al., “6-Heteroaryl-pyrazolo[3,4-b]pyridines: Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 (GSK-3),”Bioorganic&Medicinal Chemistry Letters, 13 (2003) 3059-3062.
Almansa Rosales Carmen
Bernadó Marina Virgili
Palau Pharma, S.A.
Rahmani Niloofar
Rothwell Figg Ernst & Manbeck
Seaman D. Margaret
LandOfFree
Pyrazolopyridine derivates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyridine derivates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyridine derivates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4037997